Bacterial DNA Translocation Is Associated With Systemic Circulatory Abnormalities and Intrahepatic Endothelial Dysfunction in Patients With Cirrhosis
Open accessAbstract
Presence of bacterial DNA in noninfected patients with cirrhosis and ascites is associated with a marked inflammatory response including activation of the inducible form of nitric oxide synthase and release of nitric oxide, similar to that observed in patients with sponta-neous bacterial peritonitis. Although presence of bacterial DNA is associated with an impaired prognosis, no information is available regarding its hemodynamic consequences. Systemic and hepatic hemodynamics before and after a liquid test meal were assessed in a series of 75 noninfected patients with cirrhosis (55 with ascites). Bacterial DNA was meas-ured by polymerase chain reaction. Bacterial DNA was detected only in patients with asci-tes. Clinical data and liver function were similar in ascitic patients with presence (n 5 21) or absence of bacterial DNA (n 5 34). Bacterial-DNA(1) patients had significantly lower mean arterial pressure ( P 5 0.002) and systemic vascular resistance ( P 5 0.03) than bacte-rial-DNA(2) patients. Cardiac output, cardiopulmonary pressures, hepatic venous pres-sure gradient (HVPG), and hepatic blood flow were similar in both groups. Thirty minutes after the test meal, in response to increased blood flow caused by postprandial hy-peremia, there was a significantly greater increase in HVPG and impaired hepatic vasore-laxation in bacterial-DNA(1) as compared with bacterial-DNA(2) patients, which indicates hepatic endothelial dysfunction. Indeed, the increase in HVPG after the test meal significantly correlated with serum bacterial DNA concentration. Conclusion: Pres-ence of bacterial DNA, a marker of bacterial translocation, is associated with aggravation of peripheral vasodilation and with worsening of intrahepatic endothelial dysfunction. (HEPATOLOGY 2010;52:2044-2052)
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Bacterial DNA, a TLR9 agonist, is increased in the peripheral blood of patients with chronic liver disease.
“Moreover, there is an increase in bacterial DNA , a well-established TLR9 agonist, in the peripheral blood of patients with CLD29.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 45 · Cited by 219
Research works printed but not linked: 1
- Navasa M, Bosch J, Mastai R, Bruix J, Rodes J. Measurement of he- patic blood-flow, hepatic extraction and intrinsic clearance of indocya- nine green in patients with cirrhosis-Comparison of a noninvasive pharmacokinetic method with measurements using hepatic vein cathe- terization. Eur J Gastroenterol Hepatol 1991;73:305-312.
- Authors
- Bellot, P., Garc´ıa-Paga´n, J. C., France´s, R., Abraldes, J. G., Navasa, M., Pe´rez-Mateo, M., Such, J., & Bosch, J.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- Corresponding author
- Bosch, Jaime
- Venue
- Hepatology
- Published
- 2010-12
- Volume
- 52
- Issue
- 6
- Pages
- 2044-2052
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2072478284
- Cited by
- 219
- References
- 45
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 15 · 2023: 16 · 2022: 6 · 2021: 31 · 2020: 14 · 2019: 15 · 2018: 18 · 2017: 10 · 2016: 21 · 2015: 22 · 2014: 17 · 2013: 4 · 2012: 9
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Banco Bilbao Vizcaya Argentaria
- Instituto de Salud Carlos III
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Keywords
- bacterial translocation, liver cirrhosis, ascites, systemic hemodynamics, hepatic venous pressure gradient, systemic vascular resistance, peripheral vasodilation, nitric oxide synthase
- MeSH terms
- Adult, Aged, Ascites, Bacterial Infections, DNA, Bacterial, Female, Hemodynamics, Humans, Liver, Liver Circulation, Liver Cirrhosis, Male, Middle Aged, Vascular Resistance, Bacterial Translocation, Postprandial Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review